Acquisition of Chromatography Technology Platform
Repligen has announced that it acquired the assets of BioFlash Partners for $1.8 million, which includes a technology platform for the production of pre-packed, ?plug and play? chromatography columns.
Repligen has announced that it acquired the assets of BioFlash Partners for $1.8 million, which includes a technology platform for the production of pre-packed, ‘plug and play’ chromatography columns.
According to the company this technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.
“We are very pleased to have acquired the BioFlash platform, a technology which will enable us to meet the growing market need for flexible, pre-packed chromatography products,” said Walter C. Herlihy, president and CEO of Repligen in a statement.
The company reports that products based on the acquired technology will be offered in a range of column diameters and bed heights and can be prepacked with commercially available chromatography resins including immobilized Protein A.
The terms of the acquisition also include a contingent milestone and royalties based on product sales.
For more information visit www.repligen.com
Linking LC-HRMS Features to Aquatic Toxicity: A Nontargeted Approach Without Compound Identification
July 7th 2025A recent study conducted by the University of Amsterdam (Amsterdam, Netherlands) and the University of Queensland (Queensland, Australia) developed a novel prioritization strategy that directly links fragmentation and chromatographic data to aquatic toxicity categories, bypassing the need for identification of individual compounds. LCGC International spoke to Viktoriia Turkina of the University of Amsterdam, lead author of the paper that resulted from this study, about their work.
Detection and Risk Assessment of Mycotoxins in Commercial Tortillas Using HPLC-Based Methods
July 4th 2025A joint study between Selçuk University (Konya, Turkey) and Hitit University (Corum, Turkey) determined the natural occurrence and concentrations of the mycotoxins ochratoxin A (OTA) and deoxynivalenol (DON) in commercially available tortillas in Turkey. Contamination levels were quantified using validated analytical methods based on high-performance liquid chromatography (HPLC) coupled with fluorescence or ultraviolet detectors (HPLC-FLD or HPLC–UV).
